Form 4: Inspire Medical Systems Director Acquires Shares in Lieu of Cash Fees

Sentiment:

SEC Form 4 Filing


Gary Lee Ellis, a director at Inspire Medical Systems, acquired 169 shares of common stock on April 14, 2025, in lieu of cash fees, according to a Form 4 filing.

Summary

  • On April 14, 2025, Gary Lee Ellis, a director of Inspire Medical Systems, acquired 169 shares of common stock.
  • The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
  • The price per share was $149.7.
  • Following the transaction, Ellis directly owns 4,595 shares of Inspire Medical Systems.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a transaction. The director taking shares instead of cash could be seen as a slightly positive signal.

Positives

  • A director's decision to take shares in lieu of cash may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it shows director alignment with company success.

Key Dates

DateDescription
04/14/2025Date of transaction: Gary Lee Ellis acquired shares of common stock.
04/16/2025Date of signature on the Form 4 filing.

Keywords

Form 4, Director, Share Acquisition, Inspire Medical Systems, INSP, Gary Lee Ellis, Non-Employee Director Compensation Policy, Equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.